UB Paderborn / Katalog / Suche / in CDI

26 – 41 von 41

Sortiert nach

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation

Journal of the International AIDS Society, 2018-01, Vol.21 (1), p.1-n/a

2018

Volltextzugriff (PDF)

Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection

HIV medicine, 2018-02, Vol.19 (2), p.132-142

2018

Volltextzugriff (PDF)

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia

Clinical infectious diseases, 2016-11, Vol.63 (9), p.1245-1253

2016

Volltextzugriff (PDF)

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

Journal of the International AIDS Society, 2021-06, Vol.24 (6), p.e25726-n/a

2021

Volltextzugriff (PDF)

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

Current HIV research, 2010-10, Vol.8 (7), p.521

2010

Volltextzugriff (PDF)

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

AIDS (London), 2009-09, Vol.23 (15), p.2029-2037

2009

Volltextzugriff (PDF)

Reference curves for CD4 T‐cell count response to combination antiretroviral therapy in HIV‐1‐infected treatment‐naïve patients

HIV medicine, 2017-01, Vol.18 (1), p.33-44

2017

Volltextzugriff (PDF)

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

AIDS (London), 2015-01, Vol.29 (2), p.193-200

2015

Volltextzugriff (PDF)

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis

AIDS (London), 2016-01, Vol.30 (3), p.503-513

Anon

2016

Volltextzugriff (PDF)

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

HIV medicine, 2018-01, Vol.19 (1), p.42-48

2018

Volltextzugriff (PDF)

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

Journal of antimicrobial chemotherapy, 2016-05, Vol.71 (5), p.1352-1360

2016

Volltextzugriff (PDF)

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Journal of antimicrobial chemotherapy, 2009-01, Vol.63 (1), p.189-196

2009

Volltextzugriff (PDF)

Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe

Journal of acquired immune deficiency syndromes (1999), 2012-03, Vol.59 (3), p.294

2012

Volltextzugriff (PDF)

Pérdidas de seguimiento de personas con infección por el VIH en la cohorte española VACH en el periodo 2013-2014: importancia de los factores sociodemográficos

Enfermedades infecciosas y microbiología clínica, 2019-06, Vol.37 (6), p.361-366

2019

Volltextzugriff (PDF)

Hepatitis C virus and human immunodeficiency virus coinfection in Spain

The Journal of infection, 2003-08, Vol.47 (2), p.117-124

2003

Volltextzugriff (PDF)

Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

Enfermedades infecciosas y microbiologia clinica (English ed.), 2019-06, Vol.37 (6), p.361-366

2019

Volltextzugriff (PDF)

Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

Clinical infectious diseases, 2008-10, Vol.47 (8), p.1083-1092

2008

Volltextzugriff (PDF)

26 – 41 von 41

Suche als RSS-Feed

Aktive Filter

ThemaHuman Immunodeficiency Virus

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(41)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(36)
Science & Technology
(36)
Hiv
(33)
Life Sciences & Biomedicine
(33)
Adult
(32)
Female
(32)
Infectious Diseases
(32)
Male
(31)
Hiv Infections - Drug Therapy
(29)
Antiretroviral Drugs
(22)
Middle Aged
(21)
Cohort Studies
(20)
Antiretroviral Therapy
(18)
Adolescent
(16)
Aids
(16)
Anti-Hiv Agents - Therapeutic Use
(16)
Cd4 Lymphocyte Count
(16)
Immunology
(16)
Acquired Immune Deficiency Syndrome
(15)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation

Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection

Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 Study

Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy

Reference curves for CD4 T‐cell count response to combination antiretroviral therapy in HIV‐1‐infected treatment‐naïve patients

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort

Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe

Pérdidas de seguimiento de personas con infección por el VIH en la cohorte española VACH en el periodo 2013-2014: importancia de los factores sociodemográficos

Hepatitis C virus and human immunodeficiency virus coinfection in Spain

Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors

Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903

Aktive Filter

Suchergebnisse filtern